- Home
- GENC vs ARCT Comparison
GENC vs ARCT Comparison
Compare GENC & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GENC | ARCT |
|---|---|---|
| Founded | N/A | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 205.4M | 192.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GENC | ARCT |
|---|---|---|
| Price | $15.22 | $7.55 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 11 |
| Target Price | $16.00 | ★ $38.44 |
| AVG Volume (30 Days) | 28.3K | ★ 510.7K |
| Earning Date | 02-06-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9.17 | N/A |
| EPS | ★ 1.04 | N/A |
| Revenue | ★ $107,598,000.00 | $97,601,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $14.23 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.80 | $5.85 |
| 52 Week High | $17.40 | $24.17 |
Technical Indicators
Market Signals| Indicator | GENC | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 55.38 | 49.62 |
| Support Level | $13.51 | $7.00 |
| Resistance Level | $14.53 | $7.95 |
| Average True Range (ATR) | 0.50 | 0.37 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 62.58 | 30.00 |
Price Performance
Historical ComparisonAbout GENC Gencor Industries Inc.
Gencor Industries Inc and its subsidiaries is a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company has one reporting segment, equipment for the highway construction industry. The firm's principal products include asphalt plants, combustion systems, hot mix asphalt plants, fluid heat transfer systems, and asphalt pavers.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.